Access
This article is part of Nature's premium content.
Published online 9 September 2004 | Nature | doi:10.1038/news040906-15
News
Medical journals tackle biased reporting of results
Editors say trials must be registered if researchers plan to publish.
Editors of the world's leading medical journals said yesterday that drug companies should disclose more information about studies of new medicines.
The editors' statement was released on 8 September, the day before a highly anticipated public hearing on clinical trial data at the US Congress.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.